| |
 |
|
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/184 |
Heavy metal containing (including salts) |
555 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
269 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
180 |
| 514/210.01 |
Hetero ring is four-membered and includes at least one ring nitrogen |
166 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
168 |
| 514/212.01 |
Hetero ring is seven-membered consisting of one nitrogen and six carbons |
229 |
| 514/218 |
Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms |
854 |
| 514/222.2 |
Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members |
166 |
| 514/228.8 |
Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) |
266 |
| 514/241 |
Hetero ring is six-membered consisting of three nitrogens and three carbon atoms |
587 |
| 514/247 |
Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) |
743 |
| 514/277 |
Hetero ring is six-membered consisting of one nitrogen and five carbon atoms |
866 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
597 |
| 514/430 |
Sulfur containing hetero ring |
107 |
| 514/449 |
Oxygen containing hetero ring |
562 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5945423 |
Fungicidal fused bicyclic pyrimidinones |
Aug. 31, 1999 |
| 5942247 |
Method for treating pediatric high grade astrocytoma including brain stem glioma |
Aug. 24, 1999 |
| 5939098 |
Cancer treatment with temozolomide |
Aug. 17, 1999 |
| 5939415 |
[A]-annellated pyrrole derivatives and their use in pharmacology |
Aug. 17, 1999 |
| 5935973 |
Heterocyclcarboxamide derivatives and their use as therapeutic agents |
Aug. 10, 1999 |
| 5932196 |
Buffered emulsion compositions containing actives subject to acid or base hydrolysis |
Aug. 3, 1999 |
| 5932566 |
Ansamycin derivatives as antioncogene and anticancer agents |
Aug. 3, 1999 |
| 5932593 |
Piperidine derivatives and anti-platelet agents containing the same |
Aug. 3, 1999 |
| 5929063 |
Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
Jul. 27, 1999 |
| 5925631 |
Alkylated styrenes as prodrugs to COX-2 inhibitors |
Jul. 20, 1999 |
| 5919777 |
Compounds with growth hormone releasing properties |
Jul. 6, 1999 |
| 5919926 |
Salinamides |
Jul. 6, 1999 |
| 5914351 |
Anti-viral aromatic hydrazones |
Jun. 22, 1999 |
| 5906977 |
Conjugate for treating inflammatory diseases |
May. 25, 1999 |
| 5891869 |
Basic oxazoline-amide derivatives of GE2270 and GE2270-like antibiotics |
Apr. 6, 1999 |
| 5891870 |
Protein kinase C modulators Q |
Apr. 6, 1999 |
| 5885979 |
N-containing condensed heterocyclic compounds, their production, and their uses |
Mar. 23, 1999 |
| 5886017 |
Protein kinase C modulators. E. |
Mar. 23, 1999 |
| 5886019 |
Protein kinase C modulators. F. |
Mar. 23, 1999 |
| 5880136 |
Sulfonamide fibrinogen receptor antagonists |
Mar. 9, 1999 |
| 5880155 |
Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them |
Mar. 9, 1999 |
| 5877170 |
Substitute caprolactams and derivatives thereof useful for treatment of HIV disease |
Mar. 2, 1999 |
| 5877184 |
Macrolides having immunosuppressive activity |
Mar. 2, 1999 |
| 5874402 |
Use of cell membrane permeants in the treatment of cellular proliferative diseases |
Feb. 23, 1999 |
| 5874421 |
Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
Feb. 23, 1999 |
| 5871753 |
Regulated transcription of targeted genes and other biological events |
Feb. 16, 1999 |
| 5872124 |
Treatment of diseases of the central nervous system using uric acid as a scavenger of peroxynitrite |
Feb. 16, 1999 |
| 5869476 |
Pyrimidinone derivatives |
Feb. 9, 1999 |
| 5869481 |
Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making |
Feb. 9, 1999 |
| 5866562 |
Ring-bridged bis-quinolines |
Feb. 2, 1999 |
| 5866583 |
Substituted 2,4-diaminopyrimidines |
Feb. 2, 1999 |
| 5861375 |
Antiprotozoal cyclic tetrapeptides |
Jan. 19, 1999 |
| 5861429 |
13-substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests |
Jan. 19, 1999 |
| 5856318 |
Nitrogen-containing cyclohetero cyclo-heteroaminoaryl derivatives for CNS disorders |
Jan. 5, 1999 |
| 5856331 |
Method for preventing tissue injury from hypoxia |
Jan. 5, 1999 |
| 5854234 |
Amidino dervatives useful as nitric oxide synthase inhibitors |
Dec. 29, 1998 |
| 5852006 |
N-aminoalkyl-substituted nitrogen-containing six membered heterocyclic compounds |
Dec. 22, 1998 |
| 5852007 |
Cysteine and serine protease inhibitors containing D-amino acid at the P2 position, methods of making same, and methods of using same |
Dec. 22, 1998 |
| 5852018 |
Pharmaceutical piperazine compounds |
Dec. 22, 1998 |
| 5849730 |
Process for preparing demethylrapamycins |
Dec. 15, 1998 |
| 5849731 |
Indole derivatives and medical application thereof |
Dec. 15, 1998 |
| 5849755 |
3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them |
Dec. 15, 1998 |
| 5846990 |
Substituted biphenyl isoxazole sulfonamides |
Dec. 8, 1998 |
| 5843935 |
Protein kinase C inhibitors |
Dec. 1, 1998 |
| 5843950 |
1,4-dihydropyridine compound and pharmaceutical composition containing the same |
Dec. 1, 1998 |
| 5843959 |
Methods and bicyclic polyamine compositions for the treatment of inflammation |
Dec. 1, 1998 |
| 5837703 |
Amino-alcohol substituted cyclic compounds |
Nov. 17, 1998 |
| 5837717 |
Hydroxamic acid anesthetic compounds |
Nov. 17, 1998 |
| 5834199 |
Methods of identifying transition metal complexes that selectively cleave regulatory elements of mRNA and uses thereof |
Nov. 10, 1998 |
| 5834454 |
Substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof |
Nov. 10, 1998 |
|
|
|
